Description

MetLife: What New Product Launches and Bancassurance Strength Mean for Sustaining Sales Growth in Asia!

MetLife reported a robust performance in the third quarter of 2025, driven by diverse business segments and a strategic focus on capital-efficient growth initiatives. Adjusted earnings rose to $1.6 billion, translating to $2.37 per share, a 22% increase from the prior year. Core drivers included strong investment margins, particularly from private equity investments, and favorable underwriting results across several sectors. A return to normal in the disability sector and improved dental profitability were significant contributors to the uplift in the Group Benefits segment, where adjusted earnings increased 6%. Positively, MetLife’s diversified strategy is showcased by the robust performance across various geographical regions. Sales activity in Asia was notably strong, with a 34% increase driven by product launches and enhancements in Japan. Other standout markets included Korea and China, supported by growing bancassurance partnerships.